BEARDSLEY, ROBERT A.,RILEY, DENNIS P.,KEENE, JEFFERY L.,SPITZ, DOUGLAS R., JR.,FATH, MELISSA A.
申请号：
CA3022699
公开号：
CA3022699A1
申请日:
2017.05.03
申请国别(地区):
CA
年份:
2017
代理人:
摘要：
The present disclosure generally relates to combination therapies for cancer treatment, including administration of a pentaaza macrocyclic ring complex corresponding to formula (1), and active agent that is at least one of a thioredoxin reductase inhibitor and a glutathione- depleting agent.
